Today's News | Note: News feeds may no longer be available for the articles on this page.

Delcath Systems drug gets special FDA designation 8:58 AM 6/2/2009
Forbes - NY,USA
Delcath Systems Inc receieved US FDA "orphan drug" status for melphalan as a treatment for cancer affecting the body's neuroendocrine system. ...

Clinical Data's depression drug meets main goal 7:50 AM 6/2/2009
Reuters - USA
Clinical Data Inc said its experimental vilazodone drug to treat major depressive disorder (MDD) met the main goal in a second late-stage study. ...

Glaxo signs potential $1 bln deuterium drug deal 6:56 AM 6/2/2009
Reuters - USA
GlaxoSmithKline boosted its early-stage drug pipeline by signing a potential $1 billion deal with privately-held Concert Pharmaceuticals to access deuterium-containing medicines. ...

Cancer-drug results buoy biotech's stock 5:13 AM 6/2/2009
Seattle Times - United States
Cell Therapeutics said its experimental cancer drug Pixantrone increased the remission rate for patients with non-Hodgkin's lymphoma. ...

Drug Agency May Reveal More Data on Actions 4:43 AM 6/2/2009
New York Times - United States
The Obama administration plans to announce that it is setting up a task force to recommend ways to reveal more information about US FDA decisions. It may include disclosure of proprietary data on drugs and devices under study. ...

Stiefel sues KV Pharmaceutical over acne gel 4:33 AM 6/2/2009
Bizjournals.com - Charlotte,NC,USA
Stiefel Laboratories Inc sued KV Pharmaceutical Co alleging an infringement of a patent for the acne medication Duac topical gel. ...

Synta says cancer drug did not meet study goal 3:23 AM 6/2/2009
Forbes - NY,USA
Synta Pharmaceuticals Corp said its drug candidate elesclomol failed to meet its primary goal in a clinical trial testing the drug as a treatment for metastatic melanoma. ...

Heartburn drugs may raise risk of hip fractures: study 1:39 PM 6/1/2009
Reuters - USA
Short-term use of popular acid-reducing heartburn drugs may raise the risk of hip fractures. Increased risks appeared two years after patients started taking proton pump inhibitors such as Prevacid, Nexium, Prilosec, Protonix, and Aciphex. ...

Celldex Therapeutics Up On Positive Cancer Drug Results 1:09 PM 6/1/2009
Wall Street Journal - USA
Shares of Celldex Therapeutics Inc soared on positive results for two of its cancer drugs. ...

ARCA: FDA denies approval for heart drug, seeks data 10:35 AM 6/1/2009
Reuters - USA
The US FDA denied approval of ARCA biopharma Inc's experimental drug Gencaro to treat chronic heart failure in the present form. ...

Cephalon Tries Drug 'Switch' In Difficult Environment 9:05 AM 6/1/2009
Wall Street Journal - USA
Cephalon Inc has launched a campaign to switch users of its best-selling drug Provigil to the newer drug Nuvigil with longer patent protection. ...

Valeant, Schering-Plough in deal for hepatitis C drug 8:33 AM 6/1/2009
Reuters - USA
Valeant Pharmaceuticals International entered into an exclusive option agreement with Schering-Plough to develop and market Valeant's hepatitis C drug taribavirin in Japan. ...

US clears less often use of Novartis bone drug 5:04 AM 6/1/2009
Reuters - USA
The US FDA approved Novartis AG's Reclast to prevent osteoporosis in postmenopausal women with less frequent dosing. ...

OncoGenex CEO seeks prostate cancer drug partner 3:04 PM 5/31/2009
Reuters - USA
OncoGenex Pharmaceuticals Inc is looking for a partner to develop its experimental prostate cancer drug OGX-011 which extends survival by nearly seven months. ...

Exelixis brain cancer drug response rates lowered 2:24 PM 5/31/2009
Reuters - USA
Fewer patients than previously reported benefited from an experimental brain cancer drug being developed by Exelixis Inc and Bristol-Myers Squibb Co. ...

<- Day Earlier | Today's News